Literature DB >> 9025217

Urinary tract dysfunction in multiple sclerosis: is there a relation with disease-related parameters?

D Porru1, G Campus, A Garau, M Sorgia, A C Pau, G Spinici, M P Pischedda, M G Marrosu, R M Scarpa, E Usai.   

Abstract

The lower urinary tract is affected by multiple sclerosis in many patients. We screened urologically and neurologically 120 patients with a confirmed diagnosis of multiple sclerosis. The mean age was 42 years (range 22 to 69 years). Urodynamic investigation as well as neuro-urophysiological investigations were performed in all patients. Renal ultrasound was used to study morphology, and excretory urogram (IVU) was used to assess renal function and the upper urinary tracts in 105 patients. Obstructive symptoms were found more commonly than irritative symptoms. The urinary symptoms were found to be related to disease duration and not to disability status. Urodynamic abnormalities were statistically significantly related to disease duration (X2 = 38.51; P = 0.0001), and to the disability status (X2 = 76.70; P = 0.0001). Few patients, only 3.3%, had upper urinary tract dilatation. With medical management, hydronephrosis disappeared in all of the patients and did not recur. A combination of oral pharmacological agents and clean intermittent catheterization was used in the majority of the patients. We conclude that lower urodynamic abnormalities can be present in every patient with multiple sclerosis, and appear to be related to disease duration and disability status, thus early treatment based upon urodynamic evaluation and close follow-up can reduce morbidity and improve the quality of life.

Entities:  

Mesh:

Year:  1997        PMID: 9025217     DOI: 10.1038/sj.sc.3100337

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  7 in total

1.  Clinical management of the neurourological syndrome associated with multiple sclerosis and correlations to grade of the disease.

Authors:  G A Barbalias; E N Liatsikos; C Passakos; D Barbalias; G Sakelaropoulos
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 2.  Vesicourethral dysfunction in multiple sclerosis. Initial assessment based on lower urinary tract symptoms and their pathophysiology.

Authors:  Paolo Di Benedetto; Cristina Delneri; Emanuele Biasutti; Luisa Monti Bragadin; Tullio Giorgini
Journal:  Neurol Sci       Date:  2008-12       Impact factor: 3.307

Review 3.  Management of neurogenic bladder in patients with multiple sclerosis.

Authors:  Véronique Phé; Emmanuel Chartier-Kastler; Jalesh N Panicker
Journal:  Nat Rev Urol       Date:  2016-03-31       Impact factor: 14.432

Review 4.  Autonomic Dysregulation in Multiple Sclerosis.

Authors:  Alexandra Pintér; Domonkos Cseh; Adrienn Sárközi; Ben M Illigens; Timo Siepmann
Journal:  Int J Mol Sci       Date:  2015-07-24       Impact factor: 5.923

5.  Quality of life among patients with multiple sclerosis and voiding dysfunction: a cross-sectional study.

Authors:  Fatemeh Nazari; Vahid Shaygannejad; Mehrdad Mohammadi Sichani; Marjan Mansourian; Valiollah Hajhashemi
Journal:  BMC Urol       Date:  2020-06-03       Impact factor: 2.264

6.  The Impact of Neurogenic Lower Urinary Tract Symptoms and Erectile Dysfunctions on Marital Relationship in Men with Multiple Sclerosis: A Single Cohort Study.

Authors:  Riccardo Bientinesi; Simone Coluzzi; Filippo Gavi; Viviana Nociti; Carlo Gandi; Filippo Marino; Stefano Moretto; Massimiliano Mirabella; PierFrancesco Bassi; Emilio Sacco
Journal:  J Clin Med       Date:  2022-09-24       Impact factor: 4.964

7.  Prevalence of Lower Urinary Tract Symptoms in People with Multiple Sclerosis: A Systematic Review and Meta-analysis.

Authors:  Hawra B Al Dandan; Susan Coote; Doreen McClurg
Journal:  Int J MS Care       Date:  2020 Mar-Apr
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.